tetrahydropalmatine has been researched along with sch 23390 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Hao, J; Jin, H; Man, Y; Mi, W; Su, X; Sun, X; Wang, X | 1 |
| Chen, C; Chen, M; Ge, H; Qiang, K; Sun, L; Yang, Z; Zhang, J; Zhang, Y | 1 |
2 other study(ies) available for tetrahydropalmatine and sch 23390
| Article | Year |
|---|---|
Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice.
Topics: Analgesics; Animals; Benzazepines; Berberine Alkaloids; Corydalis; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Phytotherapy; Plant Preparations; Receptors, Dopamine D1 | 2014 |
Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
Topics: Animals; Bacillus subtilis; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Heterocyclic Compounds, 4 or More Rings; Ligands; Molecular Conformation; Molecular Docking Simulation; Protein Structure, Tertiary; Receptors, Dopamine D1; Receptors, Dopamine D2; Streptomyces griseus; Structure-Activity Relationship | 2019 |